HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine Tamalet Selected Research

Viremia

1/2014Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial.
9/2013Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine Tamalet Research Topics

Disease

15Infections
05/2024 - 02/2002
3HIV Infections (HIV Infection)
01/2019 - 01/2007
3Acquired Immunodeficiency Syndrome (AIDS)
10/2018 - 11/2003
3Hepatitis B
05/2016 - 05/2006
3Neoplasms (Cancer)
10/2015 - 04/2009
2Viremia
01/2014 - 09/2013
2Chronic Hepatitis B
11/2008 - 10/2007
1Reinfection
01/2020
1Uterine Cervical Dysplasia
08/2015
1Coinfection
07/2015
1Chronic Hepatitis C
01/2015
1Persistent Infection
11/2014
1Squamous Intraepithelial Lesions
04/2009
1Anus Neoplasms (Anal Cancer)
04/2009
1Lymphoma (Lymphomas)
10/2008
1Chronic Kidney Failure (Chronic Renal Failure)
05/2006
1Massive Hepatic Necrosis
02/2005

Drug/Important Bio-Agent (IBA)

7DNA (Deoxyribonucleic Acid)IBA
05/2024 - 02/2005
4Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2016 - 05/2006
4AntibodiesIBA
05/2016 - 05/2006
3RNA (Ribonucleic Acid)IBA
01/2020 - 01/2014
3Peptide Hydrolases (Proteases)FDA Link
10/2018 - 11/2003
2Rilpivirine (TMC-278)IBA
01/2019 - 04/2018
2Reverse Transcriptase InhibitorsIBA
10/2018 - 03/2009
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2018 - 11/2003
2NucleotidesIBA
01/2018 - 03/2009
1Emtricitabine (Emtriva)FDA Link
01/2019
1Tenofovir (Viread)FDA Link
01/2019
1Papillomavirus Vaccines (HPV Vaccines)IBA
01/2019
1Surface Antigens (Surface Antigen)IBA
01/2018
1Amino AcidsFDA Link
01/2018
1Messenger RNA (mRNA)IBA
08/2015
1Antiviral Agents (Antivirals)IBA
01/2015
1Protease Inhibitors (Protease Inhibitor)IBA
11/2014
1telaprevirIBA
11/2014
1InterferonsIBA
11/2014
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
11/2014
1Ribavirin (Virazole)FDA LinkGeneric
11/2014
1Transaminases (Aminotransferases)IBA
09/2013
1Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2012
1NucleosidesIBA
03/2009
1entecavirFDA Link
10/2008
1Anti-Retroviral Agents (Antiretroviral Agents)IBA
02/2002

Therapy/Procedure

7Therapeutics
07/2015 - 02/2002
4Highly Active Antiretroviral Therapy (HAART)
04/2015 - 01/2007
2Drug Therapy (Chemotherapy)
10/2015 - 04/2015
1Combination Drug Therapy (Combination Chemotherapy)
10/2008